Across TCGA pan-cancer cohorts, KRT8P38 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KRT8P38’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where KRT8P38 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT8P38 is over-expressed in tumor.

BLCA, LUAD, and LUSC are the cancer types where KRT8P38 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT8P38 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.153	.007	7	view →
LUAD	All	II,III,IV	+0.093	<.001	7	view →
LUSC	All	All	+0.076	.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: KRT8P38 RNA expression & survival · all KRT8P38 data types